|
|
|
« Go to Upcoming Event List
|
|
|
Part Two of "What's Going on in Life Sciences Deals?" Webinar Series Join Partners from Ballard Spahr’s Life Sciences Group
as they share how the data and results of the Licensing Executives
Society Royalty Rates and Deal Terms survey can be best utilized to your
benefit. The panel will discuss approaches and terms that you can
utilize in your Life Sciences deals and agreements. This program is open to Ballard Spahr clients and prospective
clients. There is no cost to attend. This program is not eligible for
CLE credits.
Please register at least two days before the webinar. Login details
will be sent to all approved registrants. For more information, contact questions@ballardspahr.com.
Thursday, November 10, 2022 | 12:00 - 1:00 PM ET .png)
| Speakers | | | Scott D. Marty
Co-Leader, Life Sciences Industry Group, Ballard Spahr LLP
678.420.9408
martys@ballardspahr.com Scott D. Marty is Co-Leader of the firm's Life Sciences Industry Group, Leader of the Patent Group's biotechnology team, and a member of the pharmaceutical team. His practice focuses on various aspects of biotechnology patent prosecution, diligence and patent litigation, including Post-Grant Proceedings before the Patent Trial and Appeal Board. | | | Andrew D. Spruiell
Life Sciences
303.379.2280
spruiella@ballardspahr.com Andrew D. Spruiell advises established and emerging companies in
corporate, licensing, commercial, and acquisitive transactions.
Andrew’s matters have involved buy- and sell-side acquisitions, initial
formation, venture capital and private equity financings, mergers and
acquisitions, strategic business partnerships and collaborations as well
as complex intellectual property licensing. | | | Ryan J. Udell
Co-Leader, Life Sciences Industry Group, Ballard Spahr LLP
215.864.8503
udellr@ballardspahr.com Ryan Udell is the Co-Leader of the firm's Life Sciences Industry Group. Headvises companies throughout the corporate life cycle—and across industry sectors—in mergers, acquisitions, sales, licensing, and capital raising. He helps emerging growth companies to secure financing and represents angel and venture capital investors in debt and equity transactions. Ryan is particularly known for his work in the technology industry. | 
| Steven N. Dupont
Life Sciences
303.379.2278
duponts@ballardspahr.com Steven N. Dupont focuses on the corporate, licensing, and
transactional needs of established and emerging life science, medical
device, biotechnology, biopharmaceutical, technology, and natural
products companies. He has extensive experience in representing public
and private companies in complex intellectual property licensing and
strategic corporate alliances.
| |
|
|
|
Print Page
